Table Of ContentAUTHOR INDEX
Abbate-Daga, G., 114 Dell’ Osso, L., 7, 69, 81 Kelly, B., 1
Abrams, K.Y., 235 Donati, D., 369 Kennedy, N., |
Ahearn, E.P., 179 Donini, M., 369 Kim, J.H., 235, 456
Ahn, Y.M., 456 Draijer, N., 195 Kim, S.W., 56, 223, 378
Alpert, J., 331 Drobny, J., 49 Kim, Y.S., 456
Amianto, F., 114, 431 Durst, R., 37 Kiriike, N., 150
Anderson, C.B., 182 Kitamura, T., 95, 219
Andreasen, N.C., 393 Eisemann, M., 210 Klein, D.N., 420
Armani, A., 69 Endicott, J., 69, 81 Klein, E., 127
Arndt, S., 393 Knobler, H.Y., 37
Askiit, D., 204 Fagiolini, A., 69 Koide, R., 474
Farmer, R.F., 285 Koshiishi, F., 219
Balzuweit, S., 385 Fassino, S., 114, 431 Koshimune, K., 150
Bandelow, B., 269 Fava, M., 331 Krecklow, B., 210
Barzega, G., 28 Flaum, M., 393 Kupfer, J., 74
Benazzi, F., 263 Fleming, F., 393 Kupper, Z., 311
Beratis, S., 438 Fossati, A., 369
Berrios, G.E., | Frank, E., 69, 81 Laibel, Z., 37
Black, D.W., 301 Franklin, C.L., 413 Laird, N.M., 13
Blazer, D.G., 41 Fricchione, G., 135 Langbehn, D., 404
Blum, N., 301 Friedmann, A., 167 Langeland, W., 195
Bogetto, F., 2% Fujii, Y., 219 Laporte, L., 448
Bollini, A., 175 Lattuada, E., 336
Bolte, S., 325 Gaither, G.A., 215 Lee, B.C., 456
Boon-Vermeeren, M., 344 Galynker, I.1., 127 Lee, H.K., 361
Brahler, E., 74 Gans, S.W., 127 Leighton, A.H., 13
Brien, D., 397 George, L.K., 41 Lekka, N.P., 438
Broocks, A., 269 Goodwin, R.D., 22, 2 Leombruni, P., 114, 431
Bulik, C.M., 182 Graham, B.G., 175 Liberman, R.P.., 469
Grant, J.E., 56, 223, 375 Lim, D., 121
Cadoret, R.J., 404 Green, M., 469 Loas, G., 397
Carroll, B.J., 179 Grilo, C.M., 108, 427 Lyoo, I.K., Ze2 35, 361
Carter, F.A., 182 Grochocinski, V.J., 69, 81 Lysacker, P.H., 319
Caspers, K., 404 Gunzelman, T., 74
Cassano, G.B., 7, 69, 81 Guo, S., 88 Mack, A.H., 135
Cassidy, F., 179 Gutkind, D., 469 Maffei, C., 369
Cassidy, G., 63 Guttman, H., 448 Maina, G., 28
Chapman, A.L., 285 Mandelli, L., 336
Chemerinski, E., 393 Hajak, G., 269 Marazziti, D., 7
Chen, C-C, 158 Hamilton, S.P., 22 Marneros, A., 385
Chen, C-S., 443 Haring, A., 385 Marshall, B.D., Jr., 469
Chen, H-M., 158 Hasui, C., 219 Maser, J.D., 69, 81
Chen, W.J., 158 Hayden, J., 469 Masheb, R.M., 108
Cheng, A.T.A., 158 Hino, T., 279 Matsui, T., 150
Chien, C.P., 474 Ho, B-C., 393 Matsunaga, H., 150
Chinman, M.J., 245 Hughes, D.C., 41 Mavissakalian, M.R., 88
Chung, H-H., 443 McDonough, M., |
Clements, C.A., 319 lizuka, S., 474 McEvoy, J.P., 63, 175
Cohen, L.J., 127 Itskovich, Y., 127 McGeoch, P.G., 127
Connor, K.M., 41 Iwasaki, Y., 150 McGorry, P., 49
Conway, C.R., 175 McIntosh, V.V., 182
Corretti, G., 69 Jackson, T.D., 108 McMillen, C., 478
Cullen, K., 127 Joyce, P.R., 182 Melhem, N.M., 463
Jung, J.H., 361 Merckelbach, H., 344
Daga, G.A., 431 Miles, V., 49
Davidson, J.R.T.. 41 Kang, U.G., 456 Mintz, J., 469
Davidson, L.K., 245 Karam, E.G., 463 Miyata, A., 150
Davis, C., 189 Katerndahl, D.A., 351 Miyata, R., 219
De Clippele, A., 142 Katz, G., 37 Modai, I., 229
Deboutte, D.,1 42 Keefe, R.S.E., 175 Monahan, P., 301
486 Comprehensive Psychiatry, Vol. 43, No (November/December), 2002: pp 486-498
AUTHOR INDEX
Abbate-Daga, G., 114 Dell’ Osso, L., 7, 69, 81 Kelly, B., 1
Abrams, K.Y., 235 Donati, D., 369 Kennedy, N., |
Ahearn, E.P., 179 Donini, M., 369 Kim, J.H., 235, 456
Ahn, Y.M., 456 Draijer, N., 195 Kim, S.W., 56, 223, 378
Alpert, J., 331 Drobny, J., 49 Kim, Y.S., 456
Amianto, F., 114, 431 Durst, R., 37 Kiriike, N., 150
Anderson, C.B., 182 Kitamura, T., 95, 219
Andreasen, N.C., 393 Eisemann, M., 210 Klein, D.N., 420
Armani, A., 69 Endicott, J., 69, 81 Klein, E., 127
Arndt, S., 393 Knobler, H.Y., 37
Askiit, D., 204 Fagiolini, A., 69 Koide, R., 474
Farmer, R.F., 285 Koshiishi, F., 219
Balzuweit, S., 385 Fassino, S., 114, 431 Koshimune, K., 150
Bandelow, B., 269 Fava, M., 331 Krecklow, B., 210
Barzega, G., 28 Flaum, M., 393 Kupfer, J., 74
Benazzi, F., 263 Fleming, F., 393 Kupper, Z., 311
Beratis, S., 438 Fossati, A., 369
Berrios, G.E., | Frank, E., 69, 81 Laibel, Z., 37
Black, D.W., 301 Franklin, C.L., 413 Laird, N.M., 13
Blazer, D.G., 41 Fricchione, G., 135 Langbehn, D., 404
Blum, N., 301 Friedmann, A., 167 Langeland, W., 195
Bogetto, F., 2% Fujii, Y., 219 Laporte, L., 448
Bollini, A., 175 Lattuada, E., 336
Bolte, S., 325 Gaither, G.A., 215 Lee, B.C., 456
Boon-Vermeeren, M., 344 Galynker, I.1., 127 Lee, H.K., 361
Brahler, E., 74 Gans, S.W., 127 Leighton, A.H., 13
Brien, D., 397 George, L.K., 41 Lekka, N.P., 438
Broocks, A., 269 Goodwin, R.D., 22, 2 Leombruni, P., 114, 431
Bulik, C.M., 182 Graham, B.G., 175 Liberman, R.P.., 469
Grant, J.E., 56, 223, 375 Lim, D., 121
Cadoret, R.J., 404 Green, M., 469 Loas, G., 397
Carroll, B.J., 179 Grilo, C.M., 108, 427 Lyoo, I.K., Ze2 35, 361
Carter, F.A., 182 Grochocinski, V.J., 69, 81 Lysacker, P.H., 319
Caspers, K., 404 Gunzelman, T., 74
Cassano, G.B., 7, 69, 81 Guo, S., 88 Mack, A.H., 135
Cassidy, F., 179 Gutkind, D., 469 Maffei, C., 369
Cassidy, G., 63 Guttman, H., 448 Maina, G., 28
Chapman, A.L., 285 Mandelli, L., 336
Chemerinski, E., 393 Hajak, G., 269 Marazziti, D., 7
Chen, C-C, 158 Hamilton, S.P., 22 Marneros, A., 385
Chen, C-S., 443 Haring, A., 385 Marshall, B.D., Jr., 469
Chen, H-M., 158 Hasui, C., 219 Maser, J.D., 69, 81
Chen, W.J., 158 Hayden, J., 469 Masheb, R.M., 108
Cheng, A.T.A., 158 Hino, T., 279 Matsui, T., 150
Chien, C.P., 474 Ho, B-C., 393 Matsunaga, H., 150
Chinman, M.J., 245 Hughes, D.C., 41 Mavissakalian, M.R., 88
Chung, H-H., 443 McDonough, M., |
Clements, C.A., 319 lizuka, S., 474 McEvoy, J.P., 63, 175
Cohen, L.J., 127 Itskovich, Y., 127 McGeoch, P.G., 127
Connor, K.M., 41 Iwasaki, Y., 150 McGorry, P., 49
Conway, C.R., 175 McIntosh, V.V., 182
Corretti, G., 69 Jackson, T.D., 108 McMillen, C., 478
Cullen, K., 127 Joyce, P.R., 182 Melhem, N.M., 463
Jung, J.H., 361 Merckelbach, H., 344
Daga, G.A., 431 Miles, V., 49
Davidson, J.R.T.. 41 Kang, U.G., 456 Mintz, J., 469
Davidson, L.K., 245 Karam, E.G., 463 Miyata, A., 150
Davis, C., 189 Katerndahl, D.A., 351 Miyata, R., 219
De Clippele, A., 142 Katz, G., 37 Modai, I., 229
Deboutte, D.,1 42 Keefe, R.S.E., 175 Monahan, P., 301
486 Comprehensive Psychiatry, Vol. 43, No (November/December), 2002: pp 486-498
SUBJECT INDEX
Monson, R.R., 13 Richter, G., 210 Sugiura, T., 219
Morita, N., 474 Ritsner, M., 229 Sung, S.M., 235
Mosley, M., 478 Ritter, K., 167 Svrakic, D., 114
Murphy, J.M., 13 Robertson, M.J., 469 Swartz, M.S., 41
Murphy, S., 127 Rogers, M.P., 135
Rovera, G., 431 Takeuchi, T., 279
Neault, N., 331 Rovera, G.G., 114, 431 Tebes, J.K., 245
Ng, B-Y., 121 Rucci, P., 69, 81 Tedlow, J., 331
Nierenberg, A., 331 Ruchkin, V., 142 Tichauer, G. A., 269
Nierenberg, A.A,, 13 Rudolf, L., 325 Tomito, T., 95
Noam, G.G., 361] Riither, E., 269 Troughton, E.P., 404
North, C., 478
Tschacher, W., 311
Novella, L., 369 Saettoni, M., 81
Tiikel, R., 204
Sakamoto, S., 219
Tiirksoy, N., 204
Ong, S-H., 121 Sandhu, H.K., 404
Ortwein-Swoboda, G., 167 Sansone, R.A., 215
Oya, K., 150 Sarno, N., 81 van den Brink, W., 195
Ozdemir, O., 204 Schanda, H., 167 Venturello, S., 28
Vermeiren, R., 142
Schiffman, S.S., 175
Pallanti, S., 7 Schwab-Stone, M., 142
Parchman, M., 351 Serretti, A., 336 Wessel. Ee 344
Paris, J., 103 Shankman, S.A., 420 Wilson, W.H., 63
Park, H-J., 456 Shear, M.K., 69, 81 Woodside, D.B., 189
Paschalis, C., 438 Shlomo, N. 65 Wright, D.E., 319
Peeters, F., 344 Silove, D., 49 Wu, P., 245
Pfanner, C., 7 Silver, H., 65
Pfohl, B., 301 Smeraldi, E., 336 Yabroudi, P.F., 463
Philibert, R., 404 Smith, E., 478 Yamanouchi, N., 27
Pierd, A., 431 Smith, M., 331 Yang,
Pillmann, f., 385 Sobol, A.M., 13 Yang,
Plascak-Hallberg, C.D., 319 Songer, D.A., 215 Yap, A-K., 121
Polania, L., 33 Spath, C., 169 Yeh, M-L., 443
Polat, A., 204 St. John, D., 301 Yen, C-F., 443
Ponziovksy, A., 229 Stanic, S., 114 Yon, V., 397
Posternak, M.A., 253 Stayner, D.A, 245 Yu, W-Y., 158
Poustka, F., 325 Steel, Z., 49 Yucuis, R., 404
Poznansky, O., 127 Stein, D.J., 150
Presta, S., 7 Stompe, T., 167 Zimmerman, M..,
Strauss, Z., 37 Zlotnick, C., 413
Renshaw, P.F., : Su, A., 121 Zweig-Frank, H., 103
SUBJECT INDEX
Abuse Agoraphobia, comorbidity (Continued)
in patients with BPD and PTSD, 44-45 comorbidity with panic attack, 23-24
see also types of abuse Agoraphobic-like symptoms, participation in long-term drug
sexual, in patients with BPD and PTSD, 44-45 treatment, 88-94
ADHD, see Attention deficit/hyperactivity disorder AGS, see Anticipatory Grief Scale
Adjustment disorder, atypical symptoms, 256 Akathisia, drug-induced
Adolescents, delinquency clinical characteristics, 458
etiological factors, 210-214
subjective emotional experience and cognitive impairment,
predicting recidivism in, 142-149
456-462
Adverse life events, early, in patients with BPD and PTSD, 44
symptoms, 456
Age
Alcohol, gender prevalence, 465
effects on alexithymia scales of elderly subjects, 78
see also Adolescents; Childhood; Elderly Alcohol abuse, family history, and panic disorder, 274
and self-harm behaviors in patients with borderline person- Alcohol abuse/dependence, and PTSD vulnerability, 481
ality disorder, 215-218 Alcohol dependence
Agoraphobia, comorbidity comorbidity with panic attack, 23-24
with major depression and bipolar disorder, 247 high-dose BZD use in, 440
488 SUBJECT INDEX
Alcohol use disorder, comorbidity with major depression and Attentional impairment, associated with drug-induced akathisia,
bipolar disorder, 247 456-462
Alcoholics, treatment-seeking, trauma and dissociation, 195- Attitude Questionnaire, correlates for hostility in post-acute
203 phase of schizophrenia spectrum disorders, 319-324
Alcoholism Autism, higher-functioning
and childhood trauma, 195-203 cognitive structure, 325-330
and posttraumatic stress disorder, 195-203 separation from schizophrenia, 325-330
preceding early-onset panic disorder, 28 Autobiographical memory specificity, and course of MDD, 344-
Alexithymia 350
age, gender, and education’s effects on elderly subjects, 78 Autobiographical Memory Test, MDD and autobiographical
connections with mood, 77 memory specificity, 344-350
and depression in elderly general population, 74-80 Avoidant personality disorder
symptoms in family context, 448-455 diagnostic comorbidity in personality disorder, 292
AMT, see Autobiographical Memory Test diagnostic efficiency statistics for personality disorder, 294
AN, see Anorexia nervosa distribution by gender, 428
Anhedonia Axis I disorders
biological underpinnings, mesolimbic dopamine system, comorbidity with OCS, 204-209
189-194 preceding onset of early-onset panic disorder, :
and depression, 15-17 Axis II disorders
in eating disorders, 189-194 and melancholia comorbidity, 331-335
and schizophrenia, 65-68 preceding onset of early-onset panic disorder, :
Anorexia nervosa
and alexithymia in women, 448-455
anhedonia in, 189-194 Barbiturates, gender prevalence, 465
family dynamics, 114-120 Barnes Akathisia Rating Scale, 456-462
personality characteristics of BARS, see Barnes Akathisia Rating Scale
patient’s parents, 118 BDHI, see Buss-Durkee Hostility Inventory
subjects, 117 BED, see Binge eating disorder
Anticipatory Grief Scale, 96 Benzodiazepines
Antipsychotic drugs high-dose users, clinical diagnoses, 440
akathisia impairment due to, 456-462 suicide attempts in high-dose users, 438-442
insomnia following withdrawal in schizophrenia, 393-: treatment, kleptomania, 8
Antisocial adult behavior, comorbidity with panic attack, 23-2 Bereavement, compared with grief, 95
Antisocial personality disorder Bereavement Phenomenology Questionnaire, 96
comorbidity in personality disorders, 292 BEST, see Borderline Evaluation of Severity Over Time
comorbidity with panic attack, 23-24 Binge eating disorder
distribution by gender, 428 gender differences, 427-430
and heroin use, 463-468 predictors, 433
Anxiety temperament and character in obese women with, 431-437
age of onset in SLE, 139 comparison with bulimia nervosa, 108-113
association with atypical depression, 253-262 Bipolar affective disorder
Anxiety disorder effect of jet lag on, 39
atypical features across, 253-262 in erotomania, 1-6
comorbidity with kleptomania, 9 Bipolar depression, atypical symptoms, 256
effect of jet lag on, 39 Bipolar disorder
gender distributions in kleptomania, 10 and cocaine use, 463-468
high-dose BZD use in, 440 comorbidity with panic attack, 23-24
in patients with kleptomania, 381 prevalence of comorbid mental disorders, 247
preceding early-onset panic disorder, 28 rapid cycling
relationship with substance abuse in severe affective disor- clinical and demographic features, 336-343
ders, 245-252 less severe psychotic features, 336-343
see also Generalized anxiety disorder; Obsessive-compulsive lower risk for suicide, 336-343
disorder; Panic disorder; Social phobia WMH in children with, 363-366
Anxious-fearful cluster, see Personality disorders Bipolar I disorder, smoking and psychosis in patients with,
Appetite disturbance, and depression, 15-17 63-64
AQ, see Attitude Questionnaire Bipolar II disorder, relationship of recurrent unipolar disorder
Attention deficit hyperactivity disorder to, 263-268
childhood, and BPD in adulthood, 369-377 Birth risk factors, and panic disorder, 269-278
comorbidity with kleptomania, 9 BN, see Bulimia nervosa
gender distributions in kleptomania, 10 Body dissatisfaction, and eating disorders, 110
SUBJECT INDEX
Body dysmorphic disorder Checking compulsion, in OCD, Y-BOCS assessment, 206
comorbidity with kleptomania, 9 Child abuse, and alcoholism in adulthood, 195-203
gender distributions in kleptomania, 10 Child Assessment Schedule, prediction of recidivism in adoles-
Borderline Evaluation of Severity Over Time, borderline per- cents, 143
sonality disorder, measurement of severity and change, Child Behavior Checklist, prediction of recidivism in adoles-
301 cents, 144
Borderline personality disorder Childhood, traumatic events and panic disorder, 271-273
and ADHD in childhood, 369-377
Childhood Abuse Questionnaire, correlates for hostility in post-
and alexithymia in women, 448-455 acute phase of schizophrenia spectrum disorders, 319-
comorbidity in personality disorder, 292 324
diagnostic efficiency statistics for personality disorder.
Childhood Trauma Questionnaire, MDD and autobiographical
distribution by gender, 428
memory specificity, 344-350
high-dose BZD use in, 440
Children, brain white matter hyperintensities on MRI in chil-
impact on post-traumatic stress, 41-48
dren with psychiatric disorders, 361-368
and post-traumatic stress symptoms
CIDI, see Composite International Diagnostic Interview
demographic characterstics of patients with, 43
Ciompi-Tschacher rating scale, symptom trajectories in psy-
early adverse life events in patients with, 44
chotic episodes, 311-318
fundamental impairment of patients, 45
health status and psychotropic medication usage, 44 Circadian rhythms, effect of disruption of on major psychiatric
predictors of outcome, 103-109 disorders, 37-40
resistance to psychiatric treatment, 302 Clark and Watson tripartite model, dimensional classification
self-harm behaviors across the life cycle, 215-218 system, 420
STEPPS treatment, 301-310 Cleaning/washing compulsion, in OCD, Y-BOCS assessment,
BPD, see Borderline personality disorder 206
BPQ, see Bereavement Phenomenology Questionnaire Clinical Interview for DSM-IV, study of subthreshold PTSD,
Brain 413-419
fear network, and development of panic disorder, 277 Cloninger’s Tridimensional Personality Questionnaire, psycho-
white matter hyperintensities on MRI in children with psy- metric properties and construct validity, 158-166
chiatric disorders, 361-368 Cluster C personality disorders, in early-onset panic disorder
Brief Symptom Inventory, 229 patients, 34
BSI, see Brief Symptom Inventory Cocaine
Bulimia nervosa gender prevalence, 465
anhedonia in, 189-194 use and bipolar disorder, 463-468
comparison with binge-eating disorder, 108-113 use disorder, comorbidity with major depression and bipolar
effect of CBT on temperament and character, 182-188 disorder, 247
preceding early-onset panic disorder, 28, 31, 33 Cognition, in drug-induced akathisia, 456-462
Buspirone, treatment, kleptomania, 8 Cognitive structure, in higher-functioning autism versus schizo-
Buss-Durkee Hostility Inventory, correlates for hostility in post- phrenia, 325-330
acute phase of schizophrenia spectrum disorders, 319-
Cognitive-behavioral systems-based group treatment, border-
324
line personality disorder, 301-310
BZD, see Benzodiazepines
Cognitive-behavioral therapy, for bulimia nervosa, effect on
temperament and character, 182-188
California Verbal Learning Test, haloperidol versus risperidone
Comorbidity
study, 469-473
ADHD and kleptomania, 9
Cannabis
agoraphobia, major depression, and bipolar disorder, 247
gender prevalence, 465
alcohol
use and schizophrenia, 463-468
dependence and panic attack, 23-24
use disorder, comorbidity with major depression and bipolar
use disorder, major depression, and bipolar disorder,
disorder, 247
247
CAQ, see Childhood Abuse Questionnaire
antisocial adult behavior and panic attack, 23-24
Carbamazepine, treatment, erotomania, 5
CAS, see Child Assessment Schedule anxiety disorder and kleptomania, 9
Catatonia, types in schizophrenia, 168 axis I disorders and melancholia, 331-335
Catatonic schizophrenia, 167-174 bipolar disorder
CBC, see Child Behavior Checklist and mental disorders, 247
CBI, see Core Bereavement Items and panic attack, 23-24
CBT, see Cognitive-behavioral therapy body dysmorphic disorder and kleptomania, 9
Character borderline personality disorder, 292
and adolescent delinquency, 210-214 cannabis use, major depression, and bipolar disorder, 247
in obese women with BED, 431-437 cocaine use, major depression, and bipolar disorder, 247
measurement in anorexia nervosa patients, 114 conduct disorder and panic attack, 23-24
490 SUBJECT INDEX
Comorbidity (Continued) Core Bereavement Items, 96
dysphoria Counting compulsion, in OCD, Y-BOCS assessment, 206
and OCD, 206 CT, see Ciompi-Tschacher rating scale
and panic attack, 23-24 CTQ, see Childhood Trauma Questionnaire
eating disorders and kleptomania, 9 CVLT, see California Verbal Learning Test
GAD and OCD, 206
GAD, major depression, and bipolar disorder, 247
DA, see Dopaminergic
hallucinogen use, major depression, and bipolar disorder, 247
Daily living, treatment impact of risperidone versus haloperidol
hypochondriasis and OCD, 206
on in refractory schizophrenia, 469-473
impulse control disorder and kleptomania, 9
DAPI-Q, see Dimensional Assessment of Personality Impair-
major depression
and mental disorders, 247 ment-Questionnaire
DD, see Delusional disorder
panic attack and mental disorders, 23
Death, thoughts of, and depression, 15-17
and panic disorder in subthreshold and full PTSD
and PTSD, 416 Delinquency, adolescent
etiological factors, 204-209
major depressive disorder
predicting recidivism in, 142-149
and axis II disorders, 331-335
Delusion, see also Erotomania
and panic attack, 23-24
mania and OCD, 206 Delusional disorder
in erotomania, 3
melancholia and axis II disorders, 331-335
reasoning in, 175-178
mood disorders and kleptomania, 8, 9
sensory acuity in, 175-178
nonaffective psychosis and panic attack, 23-24
Dementia, age of onset in SLE, 139
obsessive-compulsive disorder
and kleptomania, 8, 9 Demographics
major depression, and bipolar disorder, 247 characteristics of high-dose BZD users, 438-332
opioid use disorder, major depression and bipolar disorder, kleptomania, 379
247 rapid cycling bipolar disorder, 336-343
panic attack, 23-24 subthreshold and full PTSD, 416
major depression, and bipolar disorder, 247 Dependent personality disorder
diagnostic comorbidity in personality disorders, 292
and OCD, 206
and PTSD, 416 distribution by gender, 428
personality disorders, 292, 334 high-dose BZD use in, 440
phobia Depression
and panic attack, 23-24 age of onset in SLE, 136-137, 139
and OCD, 206 and alexithymia in elderly population, 74-80
psychiatric disorders atypical, association of anxiety with, 253-262
and kleptomania, 7-12 and grief, 99
and PTSD in flood survivors, 478-48 insomnia as forerunner, 13-21
and substance abuse, 463-468 and loss of sexual interest, 16-17
PTSD melancholic and nonmelancholic, comorbidity of personality
and panic attack, 23-24 disorders, 334
and psychiatric disorders, 483 prediction of severity, 347
schizoaffective disorder, major depression, and bipolar dis- see also Major depressive disorder
order, 247 self-disparagement as forerunner, 13
stimulants use, major depression and bipolar disorder, 247 sleep disturbance as forerunner, 13-
substance abuse, 463-468 symptoms
and kleptomania, 9 as predictors of in Stirling County Study, 18
substance dependency and panic attack, 23-24 reported in Stirling County Study, 16, 17
tic disorder and kleptomania, 9 Depressive disorders, effect of jet lag on, 39
Composite International Diagnostic Interview, 195-205 Depressive symptoms, associated with drug-induced akathisia,
Conduct disorder 456-462
attention deficit disorder, WMH in children with, 363-366 Depressive personality disorder
comorbidity with panic attack, 23-24 comorbidity in personality disorders, 292
Contamination, in OCD, Y-BOCS assessment, 206 diagnostic efficiency statistics for personality disorder, 294
Continuous Performance Test, haloperidol versus risperidone DEQ, see Developmental Experiences Questionnaire
study, 469-473 DES, see Dissociative Experiences Scale
Cooperativeness, different scores for obese women with and Developmental Experiences Questionnaire, outcome assess-
without BED, 431-437 ment in BPD, 103-109
Coping Diagnosis, normal and pathological grief, 98-99
self-controlling style, and panic disorder patients, 279-284 Diagnostic Interview for Borderlines, Revised, outcome assess-
and therapeutic course in panic disorder patients, 279-284 ment in BPD, 103-109
SUBJECT INDEX
Diagnostic Interview Schedule EPQ, see Eysenck Personality Questionniare
Borderline Index, 41-48 Erotomania, 1-6
Disaster Supplement, psychiatric comorbidity and PTSD, characteristics of patients, 4, 5
478-485 diagnosis, 1-2, 3
use in Stirling County Study of depression, 13-21 Ellis and Mellsop criteria, 3
DIB-R, see Diagnostic Interview for Borderlines, Revised prognosis, 5
DIB-R, see Revised Retrospective Diagnostic Interview for rarity of cases, 4
Borderlines Erratic-dramatic cluster, see Personality disorders
Digit Span Distractibility Test, haloperidol versus risperidone ETIG, see Expanded Texas Inventory of Grief
study, 469-473 EuropASI, see European Addiction Severity Index
Dimensional Assessnent of Personality Impairment-Question- European Addiction Severity Index, 195-205
naire, study of impulsive personality traits in pedophilia, Excercisers, nonexcessive, anhedonia in, 189-194
127-134 Exercise, sensitivity to reward effects in eating disorders, 189-
Dimensional diagnosis, depression, 420-426 194
DIS, see Diagnostic Interview Schedule Expanded Texas Inventory of Grief, 96
Dissociation, in treatment-seeking alcoholics, 195-203 Eysenck Personality Questionnaire
Dissociative Experiences Scale, 195-203 predictive value, 123
Dissociative states, achieved with substance abuse, 195-203 study of dissociative trance disorder, 121-126
Dissociative trance disorder, personality profiles of patients
with, 121-126 FACES, see Family Adaptability and Cohesion Evaluation
Dopaminergic neurons, activation in reward pathway, 189 Scale
Dreamy hallucinations, in erotomania, 5 Families, alexithymia in, 448-455
Drug abuse Family, burden of mental illness on, 219-222
and gender, 465 Family Adaptability and Cohesion Evaluation Scale, study of
dependence, and PTSD vulnerability, 481 burden of mental illness on family, 219-222
Drug treatment, long-term for panic disorder, factors affecting, Family dynamics, and anorexia nervosa, 114-120
88-94 Family history
DSDT, see Digit Span Distractibility Test and panic disorder, 269-278
Duke Social Support and Stress Scale, 352-353 and pathological gambling disorder, 58-59
DUSOCS, see Duke Social Support and Stress Scale kleptomania, 11
DysD, see Dysthymic disorder Family History Research Diagnostic Criteria, in cases of klep-
Dysmorphophobia, preceding early-onset panic disorder, 28, tomania, 7-12
31,33 Family History Screen, relationship of unipolar and bipolar Il
Dysphoria disorders, 263-268
atypical symptoms, 256 Fatigue, and depression, 16-17
comorbidity FCQ, see Frankfurt Complaint Questionnaire
with OCD, 206 Fear network in brain, and development of panic disorder, 277
with panic attack, 23-24 Flesh masses, schizophrenic percepts of in Rorschach test,
and depression, 15-17 474-477
Dysthymic disorder Flood survivors, psychiatric disorders comorbidity and PTSD
dimensional diagnosis versus categorical diagnostic system, in, 478-485
420-426 Food, sensitivity to reward effects of in eating disorders, 189-
relationship to baseline symptoms, 13-21 194
Frankfurt Complaint Questionnaire, dimensional structure, 397-
Eating disorders 403
as autoaddiction, 189 Frontal lobes, WMH in children with psyschiatric disorders,
comorbidity with kleptomania, 9 361-368
gender distributions in kleptomania, 10
in patients with kleptomania, 381 GAF, see Global Assessment of Functioning
relationship to teasing about physical appearance, 108-113 Gamblers, pathological, gender differences in those seeking
see also Anorexia nervosa; Binge eating disorders; Bulimia medication treatment, 56-62
nervosa Gamblers Anonymous, treatement, pathological gambling dis-
sensitivity to reward in, 189-194 order in men and women, 59
Education, effects on alexithymia scales of elderly subject, 78 GEI, see Grief Experience Inventory
Elderly, alexithymia in, 74-80 Gender, and alexithymia, 448-455
Electroconvulsive therapy, treatment, kleptomania, 8 Gender
Emotional experience, subjective, in drug-induced akathisia, alcholism, 465
456-462 alexithymia, 78, 448-455
Emotions, see also Anhedonia binge eating disorder, 427-430
Empathy, symptoms in family context, 448-455 body dysmorphic disorder, 10
Environmental influences, in kleptomania, 223-228 in brief psychotic disorder, 387
492 SUBJECT INDEX
Gender (Continued) Harm avoidance (Continued)
comorbidity patterns in kleptomania, 8, 10 high in anorectic triad, 117
-dependent personality disorder, 428 increased in kleptomania, 223-228
differences Harrassment, and erotomania, 2, 5
in BED, 427-430 Harvard Trauma Questionnaire, study of impact of torture on
in DSM-IV personality disorders, 427-430 post-traumatic stress symptoms in Tamil refugees, 49-55
in pathological gamblers seeking medication treatment, Health-Sickness Rating Scale, use in BPD study, 104
56-62 Heroin
distribution of DSM-IV personality disorders by, 428 gender prevalence, 465
drug abuse, 465 use and antisocial personality disorder, 463-468
effects on alexithymia scales of elderly subjects, 78 Histrionic personality disorder
kleptomania, 10 comorbidity in personality disorder, 292
major depressive disorder, 427-430 distribution by gender, 428
obsessive-compulsive disorder, 428 high-dose BZD use in, 440
pathological gambling disorder, 56-62 Hoarding
personality disorders, 428 collecting, in OCD, Y-BOCS assessment, 206
and prevalence of abused substances, 465 saving, in OCD, Y-BOCS assessment, 206
Generalized anxiety disorder HOPA polymorphism, association with major depression and
atypical symptoms, 256 phobia. 404-410
comorbidity with major depression and bipolar disorder, 247 Hospitalization, predictive value of insight for in schizophrenia,
comorbidity with OCD, 206 443-447
and PTSD vulnerability, 481] Hostility, in post-acute phase of schizophrenia spectrum disor-
GEQ, see Grief Experience Questionnaire ders, correlates, 319-324
Global Assessment of Functioning HRSA, see Hamilton Rating Scale for Anxiety
follow-up study of panic disorder patients, 279-284 HRSD, see Hamilton Rating Scale for Depression
outcome assessment in BPD, 103-109 HSRS, see Health-Sickness Rating Scale
study of burden of mental illness on family, 219-222 HTQ, see Harvard Trauma Questionnaire
GMS, see Grief Measurement Scale Hypochondriasis, comorbidity with OCD, 206
GRI, see Grief Resolution Index
Grief ICG, see Inventory of Complicated Grief
clinical and research measures, 96-102 Impulse control disorder
compared with bereavement, 95 comorbidity with kleptomania, 9
in specific situations, clinical and research measures, 97-98 gender distributions in kleptomania, 10
normal versus pathological, 98-99 in patients with kleptomania, 381]
pathological, 99 see also Kleptomania
Grief Experience Inventory, 95, 96 Impulsive personality traits, in male pedophiles, 127-134
Grief Experience Questionnaire, 96 Insomnia
Grief Measurement Scale, 95, 96 as forerunner of depression, 13-21
Grief Reaction Measure, 96 following antipsychotic withdrawal in schizophrenia, 393-
Grief Resolution Index, 96 396
GRM, see Grief Reaction Measure Intelligence scores, adolescent recidivists versus nonrecidivists,
145
Hallucinations, tactile, in erotomania, 5 Interpersonal Reactivity Index, 448-455
Hallucinogen use disorder, comorbidity with major depression Interviews, measurement of OCD and SAD spectra, 81-87
and bipolar disorder, 247 Inventory of Complicated Grief, 96
Haloperidol IRI, see Interpersonal Reactivity Index
versus risperidone, treatment impact on daily living in refrac-
tory schizophrenia, 469-473 Jet lag
treatment, erotomania, 4 and melatonin, 40
HAMD, see Hamilton Rating Scale for Depression exacerbation of major psychiatric disorders, 3547 -40
HAM-D. see Hamilton Rating Scale for Depression J-TCI, see Junior Temperament and Character Inventory
Hamilton Rating Scale for Anxiety, OCD study, 204-209 Junior Temperament and Character Inventory, study of etiolog-
Hamilton Rating Scale for Depression ical factors of adolescent delinquency, 210-214
features of rapid cycling bipolar disorder, 336-343
measurement of sleep quality in schizophrenia study, 3 Kleptomania
396 clinical characteristics and associated psychopathology, 378-
melancholia and axis II disorders comorbidity, 331-335 384
OCD study, 204-209 clinical features and comorbidity, 7-12
Harm avoidance comorbidity
different scores for obese women with and without BED, with mood disorders, 8
431-437 with OCD, 8
SUBJECT INDEX 493
Kleptomania (Continued) Millon Clinical Multiaxial Inventory-II, study of impulsive
demographic characteristics, 379 personality traits in pedophilia, 127-134
DSM-IV diagnoses in patients with, 381 Montgomery-Asberg Depression Rating Scale, MDD and auto-
familial comorbidity, !1 biographical memory specificity, 344-350
gender distributions of comorbidity, 8, 10 Mood, connections with alexithymia, 77, 80
lifetime comorbid DSM-IV diagnoses, 9 Mood disorders
parental care and protection in patients with, 225 atypical features across, 253-262
temperament and early environmental influences, 223-228 cormorbidity with kleptomania, 8, 9
treatment, selective serotonin re-uptake inhibitors, 8 gender distributions in kleptomania, 10
triggers for stealing, 381 high-dose BZD use in, 440
in patients with kleptomania, 381
Lazarus Type Stress Coping Inventory, follow-up study of panic preceding early-onset panic disorder, 28
disorder patients, 279-284 rapid cycling, clinical and demographic features, 336-343
Leipzig Mood Questionnaire, 76, 78 see also Bipolar disorder; Major depressiv e disorder
Letter-Number Sequencing Subtest of the WAIS-III, correlates in SLE, 138, 139
for hostility in post-acute phase of schizophrenia spec- Mood spectrum, instruments for measuring, 69-73
trum disorders, 319-324 Mood stabilizers, treatment, kleptomania, 8
Liebowitz scale, social phobia, 82 Mood-manic domain, structure in MOOD-SR instrument, 72
Life events MOODS, SR, compared with SCI-MOODS instrument, 69-73
early traumatic, and panic disorder, 269-278 MOOD-SR, structure of the “mood-manic” domain, 72
stressful, preceding early-onset panic disorder, <
Lithium, treatment, erotomania, 5
Narcissistic personality disorder
comorbidity in personality disorders, 292
MADRS, see Montgomery-Asberg Depression Rating Scale
diagnostic efficiency Statistics for personality disorder, 294
Magnetic resonance imaging, brain white matter hyperintensi-
distribution by gender, 428
ties in children with psychiatric disorders, 361-368
high-dose BZD use in, 440
Major depression
National Comorbidity Survey, relationship between early-onset
association of HOPA polymorphism with, 404-410
panic attack and severe psychopathology, 22-27
comorbidity in PTSD, 416
Neurocognition, effects of haloperidol versus risperidone on in
prevalence of comorbid mental disorders, 247
refractory schizophrenia, 469-473
Major depressive disorder
Neuropsychiatric systemic lupus erythematosus, evidence in
and axis Il comorbidity, 331-335
support of Weinberger hypothesis, 135-141
comorbidity with panic attack, 23-24
Neuroticism, and early-onset panic disorder, 34
course, and autobiographical memory specificity, 344-350
Nonaffective pscyhosis, comorbidity with panic attack, 23
dimensional diagnosis versus categorical diagnostic system,
Novelty seeking
420-426
differing scores for obese women with and without BED,
gender differences, 427-430 431-437
in OCD pateints, 204-209
in kleptomania, 223-228
and PTSD vulnerability, 481
low in anorectic triad, 117
smoking rates in patients with, 63
NSLE, see Neuropsychiatric systemic lupus erythematosus
Major depressive episode
atypical symptoms, 256
relationship to baseline symptoms, 13-21 Obesity
Mania, comorbidity and BED, 431-437
with OCD, 206 with BED, higher risk for personality disorders, 431-437
with panic attack, 23-24 comparison between severe and moderate, 434
Manic epidsodes, recurrent, symptom profile consistency in, Obsessive Compulsive Spectrum, measuring social anxiety and
179-181 OCD spectra, 81-87
Mass of flesh, schizophrenic Rorschach percepts, 474-477 Obsessive-compulsive disorder
MCMI-II, see Millon Clinical Multiaxial Inventory-II atypical symptoms, 256
MDD, see Major depressive disorder comorbid conditions, 204-209
MDE, see Major depressive episode comorbidity
Medicinal opiate derivatives, gender prevalence, 465 of axis I disorders with, 204-209
Melancholia, and axis II comorbidity, 331-335 with kleptomania, 8, 9
Melatonin, and jet lag, 40 with major depression and bipolar disorder, 247
Memory, autobiographical in personality disorders, 292
specificity of and course of MDD, 344-350 content of symptoms, 153
specificity of relationship to self-reported childhood trauma- demographic characteristics of patients, 205
tization, 346 demographic profiles of patients, 153
Mental illness, burden on family members, 219-222 diagnostic efficiency statistics for personality disorder, 294
Mesolimbic dopamine system, and anhedonia, 189-194 distribution by gender, 428
494 SUBJECT INDEX
Obsessive-compulsive disorder (Continued) Pathological gambling disorder (Continued)
measurement of spectrum, interviews and self-report instru- gender differences, 56-62
ments, 81-87 personal and legal problems of men and women, 58
and pathological gambling disorder, 56-62 treatment history of men and women, 59
symptoms assessed with Y-BOCs Symptom Checklist, 206 triggers to gambling in men and women, 58
with poor insight, 150-157 PBI, see Parental Bonding Index
Obsessive-Compulsive Spectrum Self-Report Version, 83 PBI, see Parental Bonding Instrument
OBS-SR, see Obsessive-Compulsive Spectrum Self-Report PBS, see Perinatal Bereavement Scale
Version PD, see Panic disorder
OCD, see Obsessive-compulsive disorder Pedophilia
Odd-eccentric cluster, see Personality disorders as compulsive-aggressive disorder, 127-134
OPCRIT, see Operational Criteria for Psychotic Illness check- impulsive personality traits in, 127-134
list PERI-D, see Psychiatric Epidemiological Research Interview-
Operational Criteria for Psychotic Illness checklist, features of Demoralization Scale
rapid cycling bipolar disorder, 336-343 Perinatal Bereavement Scale, 96
Opioid use disorder, comorbidity with major depression and Perinatal Grief Scale, 96
bipolar disorder, 247 Persecution, statistical association with PTSD, 53
Own Memories on Parenting questionnaire, study of etiological Persistence, high in anorectic triad, 117
factors of adolescent delinquency, 210-214 Personal inadequacy, see Self-disparagement
Personality disorder, internal consistency of criteria, 292-293
Panic Personality disorder
with agoraphobia, atypical symptoms, 256 assessment versus definition, 285-300
without agoraphobia, atypical symptoms, 256 atypical features across, 253-262
Panic attack cluster C, in early-onset panic disorder patients, 34
comorbidity with major depression and bipolar disorder, 247 comorbidity
early-onset fearful, possible prodrome of early-onset severe and covariation based on SCID-II data, 291-292
psychopathology, 22-27 in melancholic and nonmelancholic depression, 334
and suicidal ideation, 24-25 diagnoses based on SCID-II-PQ and SCID-II data, 290-291
use of Stress Process Model in explaining outcome, 358-359 DSM-IV
Panic disorder distribution by gender, 428
abnormality in fear network in brain, 277 gender differences, 427-430
comorbidity evaluation of DSM-IV criteria assessed by Structured Clini-
in PTSD, 416 cal Interview, 285-300
with OCD, 206 high risk for in obese women with BED, 431-437
early traumatic life events, 269-278 high-dose BZD use in, 440
early-onset in OCD, 153
axis I disorders preceding onset, 32 in parents of anorexia nervosa patients, 119
axis II disorders preceding onset, 32 reliability of diagnoses, symptom ratings, and dimensional
cluster C personality disorders in patients with, 3 scores, 288-289
family comparison, 30-31 sensitivity, specificity, and predictive power of criterion fea-
premorbid conditions and precipitating events, 28-36 tures, 293-295
sociodemographic and clinical characteristics, 31 PFAMC, see Psychological factors affecting medical condition
stressful life events preceding, 32, 33 PFL, see Present Feeling About Loss
follow-up study of patients, 279-284 PGD, see Pathological gambling disorder
participation in long-term drug treatment study, 88-94 Phobia
and PTSD vulnerability, 481 association of HOPA polymorphism with, 404-410
PANSS, see Postive and Negative Symptoms Scales comorbidity with panic attack, 23-24
Paranoid personality disorder simple, comorbidity
comorbidity in personality disorders, 292 with major depression and bipolar disorder,
diagnostic efficiency statistics for personality disorder, 294 with OCD, 206
distribution by gender, 428 social, comorbidity
Parental attitudes, unfavorable, and panic disorder, 269-278 with major depression and bipolar disorder,
Parental Bonding Index, outcome assessment in BPD, 103-109 with OCD, 206
Parental Bonding Instrument, study of temperament and early PHS, see Piedmont Health Survey
environmental influences in kleptomania, 223-228 Physical Anhedonia scale, 191
Parental rearing, and adolescent delinquency, 210-214 Physical appearance, teasing about and eating disorders, 108-
Passive-aggressive 113
comorbidity in personality disorders, 292 Piedmont Health Survey, identification of post-traumatic symp-
diagnostic efficiency statistics for personality disorder, 294 toms, 4]
Pathological gambling disorder Pimozide, treatment, erotomania, 5
clinical characterstics of men and women with, 57 Polydrug abuse, and psychiatric disorders, 463-468
